Lecture 21

1.
What are the categories of drug discovery?
All compounds, drug like, lead like
2.
What are the steps to drug screeening?
Find which compounds are active hits, find out how potent the hits are
3.
What are the assays for finding molecules?
Assay to find any inhibition, assay to find inhibition response curve to find potency
4.
How are library numbers reduced?
Group compounds with similarities (chemical structure)
5.
What are the levels of protein structure?
Amino acid sequence (primary), groups of amino acids (helices, strands, random coil) (secondary), 3D structure (tertiary), structure formed in combination with other proteins (quartery)
6.
What forces bind drugs to proteins?
Van der waals, H-bonds, ionic bonds, covalent bonds
7.
What will restrict binding even if chemical properties match between drug and substrate?
Physical shape
8.
What helps binding?
Flexibility of proteins
9.
What is molecular dockiing?
predicting whether a ligand appropriately fits a binding site chemically and physically
10.
What is detrimental to binding?
Polar groups with no purpose
11.
What is the result of virtual screening of molecular docking?
Ranked list of possible matched compounds according to polar groups and chemotype
12.
What follows virtual screening?
Assay
13.
What are the four categories of molecules following assays?
True actives, true inactives, false actives, false inactives
14.
How to determine false hits?
Inhibition response curve, secondary assay
15.
What is the purpose of converting hits to leads?
Improve potency, selectivity, PDPK properties
16.
What is a hit?
A molecule that demonstrates interaction with target and has biological activity
17.
What is a lead?
A hit that has desireable characterstics (high affinity/activity), but has undesirable characteristics also (toxicity, low solubility)
18.
What is lead optimisation?
Improve deficiences (toxicity, bioavailability)